Qube Research & Technologies (QRT)
PRTK

Qube Research & Technologies (QRT)’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,028
Closed -$30.6K – 3187
2023
Q1 		$30.6K Sell
12,028
-32,584
-73% -$64.4K ﹤0.01% 2268
2022
Q4 		$83.4K Buy
44,612
+4,850
+12% +$12.1K ﹤0.01% 2040
2022
Q3 		$102K Sell
39,762
-4,687
-11% -$11.7K ﹤0.01% 1968
2022
Q2 		$86K Buy
+44,449
New +$97K ﹤0.01% 1991

Other funds holding PRTK

NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PRTK Position: Q2 2023 in Review

Qube Research & Technologies (QRT) sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2023, closing a stake of 12,028 shares — an estimated $30.6K sold.

Qube Research & Technologies (QRT) first reported a position in PRTK in Q2 2022 and held it in 4 quarters. The position peaked at $102K in Q3 2022. 66 funds tracked by Wall St. Rank hold PRTK as of Q2 2023.

  • Qube Research & Technologies (QRT) reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 12,028 Paratek Pharmaceuticals, Inc. shares in Q2 2023, an estimated $30.6K.
  • Qube Research & Technologies (QRT) first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2022 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s Paratek Pharmaceuticals, Inc. position peaked at $102K in Q3 2022.
  • 66 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2023, filed 14 Aug 2023.